Sandra Panem PhD

Sandra Panem PhD is a declared insider of Acorda Therapeutics Inc, with filings sourced from SEC (Form 4). In total, 38 filings cover trades dated from 15 February 2006 to 12 December 2014.

Both buying and selling appear: 1 purchase worth €210k, against 23 sales worth €16.1M. On balance, insiders were net sellers of €15.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant and 7 option exercises. In 2014 alone, the filings show no purchases and 1 sale.

On 16 December 2014 came the latest disclosure, an option exercise for €255k in Acorda Therapeutics Inc. The last insider purchase was made public on 17 February 2006, 7,570 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.